Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:


Gene doping detectable with a simple blood test

German scientists from Tübingen and Mainz have developed a blood test that can reliably detect gene doping even after 56 days

Scientists at the universities in Tübingen and Mainz have developed a test that can provide conclusive proof of gene doping.

"For the first time, a direct method is now available that uses conventional blood samples to detect doping via gene transfer and is still effective if the actual doping took place up to 56 days before," Professor Perikles Simon, MD, PhD from Johannes Gutenberg University Mainz, Germany explained on Thursday.

"This represents a relatively low-cost method of detecting several of the most common doping genes," Simon stated in the presentation of the process. It was previously impossible to prove that an athlete had undergone gene doping. "The process of inserting individual genes in specific body cells stems from the idea of curing severe illnesses with this new technology.

It was previously thought that it would only be possible to detect gene doping via gene transfer using an extremely costly indirect test procedure from the field of molecular medicine," explained gene therapist Professor Michael Bitzer, MD from the University Hospital of the Eberhard Karls University of Tübingen.

The gene doping study conducted by the scientists from Tübingen and Mainz was published in the online edition of the internationally renowned scientific journal "Gene Therapy" on Thursday. According to the study, the test provides clear "yes-or-no answers" based on whether or not so-called transgenic DNA is present in blood samples. Transgenic DNA or tDNA does not stem from the person being tested but has been transferred into their body – often via viruses – in order to create performance-enhancing substances such as erythropoetin (EPO) for forming red blood cells. "The body of a gene-doped athlete produces the performance-enhancing hormones itself without having to introduce any foreign substances to the body. Over time, the body becomes its own doping supplier," explained Simon. In 2006, as a member of the University Hospital in Tübingen, he developed a procedure that enables even the tiniest traces of transgenic DNA to be detected in the blood. The efficiency of this procedure has now been proven for the first time in laboratory mice. A key component of the animal procedure was a sophisticated process that was able to insert the foreign genetic material extremely specifically to the muscles around a small puncture area.

This triggers excess production of a hormone, which prompts the generation of new blood vessels. Even two months after the genes were injected into the muscles, researchers were able to differentiate clearly between the mice subjected to gene doping and those that were not. "The development of a reliable method for detecting misuse of gene transfer will be used to ensure that this new technology, for which the side effects are only partially known, is used exclusively in the treatment of severe diseases," stated Bitzer. Over the next few months, the University Hospital in Tübingen is planning a relevant therapy study for advanced tumor patients.

The safe and sensitive detection procedure developed by the scientists in Mainz and Tübingen was then proven in a so-called specificity test on 327 blood samples taken from professional and recreational athletes. Researchers now believe that athletes will no longer profit from the misuse of gene therapy for doping purposes. "At the very least, the risk of being discovered months after the gene transfer has taken place should deter even the most daring dopers," Simon believes. The World Anti Doping Agency (WADA) has financed this research over the past four years with a total of 980,000 US Dollars.

Petra Giegerich | idw
Further information:

More articles from Life Sciences:

nachricht Novel mechanisms of action discovered for the skin cancer medication Imiquimod
21.10.2016 | Technische Universität München

nachricht Second research flight into zero gravity
21.10.2016 | Universität Zürich

All articles from Life Sciences >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: New 3-D wiring technique brings scalable quantum computers closer to reality

Researchers from the Institute for Quantum Computing (IQC) at the University of Waterloo led the development of a new extensible wiring technique capable of controlling superconducting quantum bits, representing a significant step towards to the realization of a scalable quantum computer.

"The quantum socket is a wiring method that uses three-dimensional wires based on spring-loaded pins to address individual qubits," said Jeremy Béjanin, a PhD...

Im Focus: Scientists develop a semiconductor nanocomposite material that moves in response to light

In a paper in Scientific Reports, a research team at Worcester Polytechnic Institute describes a novel light-activated phenomenon that could become the basis for applications as diverse as microscopic robotic grippers and more efficient solar cells.

A research team at Worcester Polytechnic Institute (WPI) has developed a revolutionary, light-activated semiconductor nanocomposite material that can be used...

Im Focus: Diamonds aren't forever: Sandia, Harvard team create first quantum computer bridge

By forcefully embedding two silicon atoms in a diamond matrix, Sandia researchers have demonstrated for the first time on a single chip all the components needed to create a quantum bridge to link quantum computers together.

"People have already built small quantum computers," says Sandia researcher Ryan Camacho. "Maybe the first useful one won't be a single giant quantum computer...

Im Focus: New Products - Highlights of COMPAMED 2016

COMPAMED has become the leading international marketplace for suppliers of medical manufacturing. The trade fair, which takes place every November and is co-located to MEDICA in Dusseldorf, has been steadily growing over the past years and shows that medical technology remains a rapidly growing market.

In 2016, the joint pavilion by the IVAM Microtechnology Network, the Product Market “High-tech for Medical Devices”, will be located in Hall 8a again and will...

Im Focus: Ultra-thin ferroelectric material for next-generation electronics

'Ferroelectric' materials can switch between different states of electrical polarization in response to an external electric field. This flexibility means they show promise for many applications, for example in electronic devices and computer memory. Current ferroelectric materials are highly valued for their thermal and chemical stability and rapid electro-mechanical responses, but creating a material that is scalable down to the tiny sizes needed for technologies like silicon-based semiconductors (Si-based CMOS) has proven challenging.

Now, Hiroshi Funakubo and co-workers at the Tokyo Institute of Technology, in collaboration with researchers across Japan, have conducted experiments to...

All Focus news of the innovation-report >>>



Event News

#IC2S2: When Social Science meets Computer Science - GESIS will host the IC2S2 conference 2017

14.10.2016 | Event News

Agricultural Trade Developments and Potentials in Central Asia and the South Caucasus

14.10.2016 | Event News

World Health Summit – Day Three: A Call to Action

12.10.2016 | Event News

Latest News

Resolving the mystery of preeclampsia

21.10.2016 | Health and Medicine

Stanford researchers create new special-purpose computer that may someday save us billions

21.10.2016 | Information Technology

From ancient fossils to future cars

21.10.2016 | Materials Sciences

More VideoLinks >>>